Chemours
551 hedge funds and large institutions have $5.42B invested in Chemours in 2018 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 158 increasing their positions, 177 reducing their positions, and 69 closing their positions.
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
0.39% less ownership
Funds ownership: 77.36% → 76.97% (-0.39%)
1% less first-time investments, than exits
New positions opened: 68 | Existing positions closed: 69
1% less funds holding
Funds holding: 558 → 551 (-7)
11% less repeat investments, than reductions
Existing positions increased: 158 | Existing positions reduced: 177
11% less capital invested
Capital invested by funds: $6.1B → $5.42B (-$685M)
40% less call options, than puts
Call options by funds: $57.5M | Put options by funds: $95.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$110M |
| 2 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$107M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$31.3M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$24.6M |
| 5 |
CI Investments Inc
Toronto,
Ontario, Canada
|
+$24.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$63M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$47.5M |
| 3 |
Two Sigma Advisers
New York
|
-$31.3M |
| 4 |
Morgan Stanley
New York
|
-$30.7M |
| 5 |
GCM
Gates Capital Management
New York
|
-$29.4M |
CC Hedge Fund Activity: Q3 2018 in Review
551 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2018, worth a combined $5.42B — down 11% from $6.1B a quarter earlier.
Sellers outnumbered buyers: 69 funds closed out of CC and 68 opened new positions — a net loss of 1 holder — while 177 trimmed existing stakes and 158 added.
The largest buyer was Fidelity Investments, adding an estimated $110M. The largest seller was AQR Capital Management, cutting an estimated $63M.
- 551 institutional investors held Chemours (CC) as of Q3 2018, down from 558 in Q2 2018.
- Funds reported $5.42B of Chemours stock for Q3 2018, down 11% quarter-over-quarter.
- 68 funds opened new Chemours positions in Q3 2018 and 69 closed out, a net change of -1 holder.
- The largest Chemours buyer in Q3 2018 was Fidelity Investments, an estimated $110M added.
- The largest Chemours seller in Q3 2018 was AQR Capital Management, an estimated $63M sold.
Based on aggregated 13F filings for Q3 2018.